Skip to main content

Table 2 Demographic characteristic of COVID-19 patients, (n = 4043)

From: The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective

Variables

 

n (%)

Antibiotic use

p-value*

Age

 ≤ 65 years

3720 (92.0)

572 (15.4)

 < 0.001

 > 65 years, median (IQR)

323 (8.0)

126 (38.9)

Gender

Male

2628 (65.0)

488 (18.6)

 < 0.001

Female

1415 (35.0)

21 (14.8)

Ethnicity

Malay

3119 (77.2)

498 (16.0)

 < 0.001a

Chinese

333 (8.2)

67 (20.1)

Indian

115 (2.8)

18 (15.7)

Orang Asli Semenanjung

4 (0.1)

0 (0.0)

Bumiputera Sabah

191 (4.7)

64 (33.5)

Bumiputera Sarawak

281 (7.0)

51 (18.1)

Number of comorbidities

No comorbidity

2549

258 (10.1)

 < 0.001b

1

834 (20.6)

205 (24.6)

2

373 (9.2)

120 (32.2)

3

194 (4.8)

74 (38.1)

4

68 (1.7)

31 (45.6)

5

20 (0.5)

7 (35.0)

6

4 (0.1)

2 (50.0)

7

1 (0.02)

1 (100.0)

Types of comorbidities

Hypertension

824 (20.4)

270 (32.8)

 < 0.001

Diabetes mellitus

517 (12.8)

204 (39.5)

 < 0.001

Dyslipidaemia

215 (5.3)

49 (22.8)

0.028

Asthma

176 (4.4)

35 (19.9)

0.347

Chronic cardiac disease

172 (4.3)

64 (37.2)

 < 0.001

Chronic kidney disease

92 (2.3)

60 (65.2)

 < 0.001

Obesity

73 (1.8)

19 (26.0)

0.046

Malignant neoplasm

40 (1.0)

15 (37.5)

0.001

Rheumatologic disorder

33 (0.8)

13 (39.4)

0.001

Chronic neurological disorder

32 (0.8)

12 (37.5)

0.002

Chronic pulmonary disease

28 (0.7)

19 (67.9)

 < 0.001

Liver disease

10 (0.3)

2 (20.0)

0.822

Chronic hematologic disease

7 (0.2)

0 (0.0)

0.103#

AIDS/HIV

7 (0.2)

0 (0.0)

0.103

Dementia

4 (0.1)

1 (25.0)

0.697#

Smoking

Smoker

500 (12.4)

53 (16.9)

0.851

Non-smoker

3543 (87.6)

645 (17.3)

  1. IQR interquartile range; AIDS acquired immunodeficiency syndrome; HIV human immunodeficiency virus
  2. a Chi-square analysis of Malay and non-Malay ethnicity
  3. b Chi-square analysis of no comorbidity vs 1, 2 and more than 2 comorbidities
  4. * Chi-Square test
  5. # Fisher's Exact test